Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for Naltrexone Initiation in Opioid Use Disorder
NCT03345173Phase 3Active, not recruiting
- Sponsor
- New York State Psychiatric Institute
- Start
- Nov 2017
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Nov 2017; status: active, not recruiting.
02
Drugs
ketamine
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT03345173.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03345173.